| Symbol |
Name |
Standardized Value |
|
BTK
|
Bruton agammaglobulinemia tyrosine kinase
|
3.329
|
|
MYD88
|
myeloid differentiation primary response 88
|
3.052
|
|
MYOM2
|
myomesin 2
|
2.822
|
|
LOC102723407
|
putative V-set and immunoglobulin domain-containing-like protein IGHV4OR15-8
|
2.635
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
2.592
|
|
CD79B
|
CD79b molecule, immunoglobulin-associated beta
|
2.537
|
|
CD5
|
CD5 molecule
|
2.505
|
|
CD19
|
CD19 molecule
|
2.498
|
|
SDC1
|
syndecan 1
|
2.377
|
|
B2M
|
beta-2-microglobulin
|
2.363
|
|
MAG
|
myelin associated glycoprotein
|
2.341
|
|
CD38
|
CD38 molecule
|
2.318
|
|
MME
|
membrane metallo-endopeptidase
|
2.251
|
|
PLCG2
|
phospholipase C, gamma 2 (phosphatidylinositol-specific)
|
2.224
|
|
ITK
|
IL2-inducible T-cell kinase
|
2.179
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
2.176
|
|
HCK
|
HCK proto-oncogene, Src family tyrosine kinase
|
2.172
|
|
IRAK4
|
interleukin-1 receptor-associated kinase 4
|
2.16
|
|
CD22
|
CD22 molecule
|
2.135
|
|
CD79A
|
CD79a molecule, immunoglobulin-associated alpha
|
2.118
|
|
IRAK1
|
interleukin-1 receptor-associated kinase 1
|
2.114
|
|
CARD11
|
caspase recruitment domain family, member 11
|
2.033
|
|
SYK
|
spleen tyrosine kinase
|
1.969
|
|
ALB
|
albumin
|
1.964
|
|
TNFSF13B
|
tumor necrosis factor (ligand) superfamily, member 13b
|
1.954
|
|
TP53
|
tumor protein p53
|
1.922
|
|
BCL6
|
B-cell CLL/lymphoma 6
|
1.916
|
|
PIK3CD
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta
|
1.887
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
1.844
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
1.836
|
|
IBTK
|
inhibitor of Bruton agammaglobulinemia tyrosine kinase
|
1.828
|
|
BCR
|
breakpoint cluster region
|
1.828
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
1.822
|
|
PAX5
|
paired box 5
|
1.813
|
|
CCND1
|
cyclin D1
|
1.811
|
|
CD27
|
CD27 molecule
|
1.803
|
|
TNFAIP3
|
tumor necrosis factor, alpha-induced protein 3
|
1.801
|
|
LYN
|
LYN proto-oncogene, Src family tyrosine kinase
|
1.796
|
|
PRDM1
|
PR domain containing 1, with ZNF domain
|
1.787
|
|
TRAF3
|
TNF receptor-associated factor 3
|
1.786
|
|
IL6
|
interleukin 6
|
1.763
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
1.754
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
1.753
|
|
PIK3CB
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta
|
1.732
|
|
MALT1
|
MALT1 paracaspase
|
1.709
|
|
BMX
|
BMX non-receptor tyrosine kinase
|
1.7
|
|
KMT2D
|
lysine (K)-specific methyltransferase 2D
|
1.697
|
|
CD52
|
CD52 molecule
|
1.689
|
|
MCL1
|
myeloid cell leukemia 1
|
1.689
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
1.685
|
|
ARID1A
|
AT rich interactive domain 1A (SWI-like)
|
1.682
|
|
NCAM1
|
neural cell adhesion molecule 1
|
1.681
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
1.677
|
|
IRF4
|
interferon regulatory factor 4
|
1.672
|
|
TXK
|
TXK tyrosine kinase
|
1.668
|
|
TNFRSF13C
|
tumor necrosis factor receptor superfamily, member 13C
|
1.661
|
|
CD40
|
CD40 molecule, TNF receptor superfamily member 5
|
1.657
|
|
BLK
|
BLK proto-oncogene, Src family tyrosine kinase
|
1.651
|
|
TNFRSF17
|
tumor necrosis factor receptor superfamily, member 17
|
1.647
|
|
CD4
|
CD4 molecule
|
1.639
|
|
TENT5C
|
terminal nucleotidyltransferase 5C
|
1.629
|
|
BCL10
|
B-cell CLL/lymphoma 10
|
1.625
|
|
PTPRC
|
protein tyrosine phosphatase, receptor type, C
|
1.624
|
|
JAK3
|
Janus kinase 3
|
1.615
|
|
EGFR
|
epidermal growth factor receptor
|
1.614
|
|
TNFRSF13B
|
tumor necrosis factor receptor superfamily, member 13B
|
1.598
|
|
ITGAE
|
integrin, alpha E (antigen CD103, human mucosal lymphocyte antigen 1; alpha polypeptide)
|
1.594
|
|
BLNK
|
B-cell linker
|
1.583
|
|
PRKCB
|
protein kinase C, beta
|
1.567
|
|
CD8A
|
CD8a molecule
|
1.564
|
|
CD40LG
|
CD40 ligand
|
1.563
|
|
CSF3
|
colony stimulating factor 3 (granulocyte)
|
1.562
|
|
BCL2L1
|
BCL2-like 1
|
1.548
|
|
BIRC3
|
baculoviral IAP repeat containing 3
|
1.547
|
|
JCHAIN
|
joining chain of multimeric IgA and IgM
|
1.54
|
|
PIK3C3
|
phosphatidylinositol 3-kinase, catalytic subunit type 3
|
1.531
|
|
TNFRSF8
|
tumor necrosis factor receptor superfamily, member 8
|
1.53
|
|
SPN
|
sialophorin
|
1.522
|
|
AICDA
|
activation-induced cytidine deaminase
|
1.518
|
|
DIS3
|
DIS3 exosome endoribonuclease and 3'-5' exoribonuclease
|
1.507
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
1.498
|
|
CRBN
|
cereblon
|
1.494
|
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
1.494
|
|
CD70
|
CD70 molecule
|
1.492
|
|
TNF
|
tumor necrosis factor
|
1.491
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
1.473
|
|
IGLL5
|
immunoglobulin lambda-like polypeptide 5
|
1.469
|
|
CR2
|
complement component (3d/Epstein Barr virus) receptor 2
|
1.466
|
|
NOTCH1
|
notch 1
|
1.456
|
|
NOTCH2
|
notch 2
|
1.454
|
|
JAK2
|
Janus kinase 2
|
1.453
|
|
VWF
|
von Willebrand factor
|
1.451
|
|
IL2
|
interleukin 2
|
1.439
|
|
CRP
|
C-reactive protein, pentraxin-related
|
1.438
|
|
BCL2L11
|
BCL2-like 11 (apoptosis facilitator)
|
1.433
|
|
STOML2
|
stomatin (EPB72)-like 2
|
1.432
|
|
IL1A
|
interleukin 1, alpha
|
1.413
|
|
ZAP70
|
zeta-chain (TCR) associated protein kinase 70kDa
|
1.41
|
|
SLAMF7
|
SLAM family member 7
|
1.4
|
|
IL1B
|
interleukin 1, beta
|
1.399
|
|
CYP3A4
|
cytochrome P450, family 3, subfamily A, polypeptide 4
|
1.391
|
|
PMAIP1
|
phorbol-12-myristate-13-acetate-induced protein 1
|
1.388
|
|
HDAC9
|
histone deacetylase 9
|
1.387
|
|
CCND3
|
cyclin D3
|
1.385
|
|
HIVEP2
|
human immunodeficiency virus type I enhancer binding protein 2
|
1.382
|
|
TBL1XR1
|
transducin (beta)-like 1 X-linked receptor 1
|
1.377
|
|
FCGR3A
|
Fc fragment of IgG, low affinity IIIa, receptor (CD16a)
|
1.376
|
|
EZH2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
1.373
|
|
CD37
|
CD37 molecule
|
1.37
|
|
CTRL
|
chymotrypsin-like
|
1.366
|
|
PPL
|
periplakin
|
1.365
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
1.361
|
|
CD34
|
CD34 molecule
|
1.355
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
1.353
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
1.347
|
|
NFKBIA
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
|
1.342
|
|
CXCL13
|
chemokine (C-X-C motif) ligand 13
|
1.334
|
|
XPO1
|
exportin 1
|
1.333
|
|
IL10
|
interleukin 10
|
1.329
|
|
CXCL9
|
chemokine (C-X-C motif) ligand 9
|
1.321
|
|
PLEK2
|
pleckstrin 2
|
1.32
|
|
HLA-G
|
major histocompatibility complex, class I, G
|
1.32
|
|
FLT3
|
fms-related tyrosine kinase 3
|
1.317
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
1.314
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
1.314
|
|
IFNG
|
interferon, gamma
|
1.313
|
|
PLEK
|
pleckstrin
|
1.311
|
|
CREBBP
|
CREB binding protein
|
1.31
|
|
A2ML1
|
alpha-2-macroglobulin-like 1
|
1.307
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
1.304
|
|
IKZF3
|
IKAROS family zinc finger 3 (Aiolos)
|
1.302
|
|
TLR9
|
toll-like receptor 9
|
1.302
|
|
USP14
|
ubiquitin specific peptidase 14 (tRNA-guanine transglycosylase)
|
1.297
|
|
NSD2
|
nuclear receptor binding SET domain protein 2
|
1.296
|
|
SOX11
|
SRY (sex determining region Y)-box 11
|
1.295
|
|
TET2
|
tet methylcytosine dioxygenase 2
|
1.295
|
|
CSK
|
c-src tyrosine kinase
|
1.293
|
|
CD274
|
CD274 molecule
|
1.286
|
|
TIRAP
|
toll-interleukin 1 receptor (TIR) domain containing adaptor protein
|
1.276
|
|
IRAK2
|
interleukin-1 receptor-associated kinase 2
|
1.275
|
|
PPEF1
|
protein phosphatase, EF-hand calcium binding domain 1
|
1.27
|
|
TCL1B
|
T-cell leukemia/lymphoma 1B
|
1.268
|
|
FCRL4
|
Fc receptor-like 4
|
1.267
|
|
CD200
|
CD200 molecule
|
1.266
|
|
EVPL
|
envoplakin
|
1.265
|
|
TEC
|
tec protein tyrosine kinase
|
1.265
|
|
ITGAX
|
integrin, alpha X (complement component 3 receptor 4 subunit)
|
1.261
|
|
TCL1A
|
T-cell leukemia/lymphoma 1A
|
1.26
|
|
CCL3
|
chemokine (C-C motif) ligand 3
|
1.257
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
1.257
|
|
TTR
|
transthyretin
|
1.251
|
|
CAMLG
|
calcium modulating ligand
|
1.24
|
|
TRAF6
|
TNF receptor-associated factor 6, E3 ubiquitin protein ligase
|
1.235
|
|
JUN
|
jun proto-oncogene
|
1.228
|
|
DSG3
|
desmoglein 3
|
1.228
|
|
IL1R1
|
interleukin 1 receptor, type I
|
1.227
|
|
DUSP22
|
dual specificity phosphatase 22
|
1.227
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
1.226
|
|
IL6R
|
interleukin 6 receptor
|
1.226
|
|
ACKR3
|
atypical chemokine receptor 3
|
1.224
|
|
GVQW3
|
GVQW motif containing 3
|
1.223
|
|
FGFR3
|
fibroblast growth factor receptor 3
|
1.222
|
|
IKZF1
|
IKAROS family zinc finger 1 (Ikaros)
|
1.211
|
|
ITGA4
|
integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor)
|
1.209
|
|
CCND2
|
cyclin D2
|
1.203
|
|
IFNA1
|
interferon, alpha 1
|
1.203
|
|
MAF
|
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog
|
1.198
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
1.197
|
|
CD33
|
CD33 molecule
|
1.196
|
|
NRAS
|
neuroblastoma RAS viral (v-ras) oncogene homolog
|
1.192
|
|
MAFB
|
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog B
|
1.186
|
|
BCL2A1
|
BCL2-related protein A1
|
1.182
|
|
JAK1
|
Janus kinase 1
|
1.177
|
|
DSG1
|
desmoglein 1
|
1.174
|
|
MAP3K14
|
mitogen-activated protein kinase kinase kinase 14
|
1.173
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
1.17
|
|
NFKB2
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100)
|
1.169
|
|
EPO
|
erythropoietin
|
1.169
|
|
SERPING1
|
serpin peptidase inhibitor, clade G (C1 inhibitor), member 1
|
1.155
|
|
DST
|
dystonin
|
1.154
|
|
HDAC4
|
histone deacetylase 4
|
1.149
|
|
ERBB4
|
erb-b2 receptor tyrosine kinase 4
|
1.148
|
|
UCHL5
|
ubiquitin carboxyl-terminal hydrolase L5
|
1.147
|
|
DNMT3A
|
DNA (cytosine-5-)-methyltransferase 3 alpha
|
1.138
|
|
MEF2B
|
myocyte enhancer factor 2B
|
1.137
|
|
MYBBP1A
|
MYB binding protein (P160) 1a
|
1.135
|
|
ATM
|
ATM serine/threonine kinase
|
1.135
|
|
NLRP3
|
NLR family, pyrin domain containing 3
|
1.131
|
|
EPPK1
|
epiplakin 1
|
1.128
|
|
IFNA17
|
interferon, alpha 17
|
1.123
|
|
F2
|
coagulation factor II (thrombin)
|
1.123
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
1.121
|
|
RELB
|
v-rel avian reticuloendotheliosis viral oncogene homolog B
|
1.116
|
|
CCL4
|
chemokine (C-C motif) ligand 4
|
1.11
|
|
BAX
|
BCL2-associated X protein
|
1.106
|
|
ARID1B
|
AT rich interactive domain 1B (SWI1-like)
|
1.104
|
|
TGFB1
|
transforming growth factor, beta 1
|
1.102
|
|
CEP70
|
centrosomal protein 70kDa
|
1.097
|
|
BIRC2
|
baculoviral IAP repeat containing 2
|
1.097
|
|
GPT
|
glutamic-pyruvate transaminase (alanine aminotransferase)
|
1.091
|
|
IFNA2
|
interferon, alpha 2
|
1.089
|
|
ASXL1
|
additional sex combs like transcriptional regulator 1
|
1.084
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
1.083
|
|
TLR7
|
toll-like receptor 7
|
1.083
|
|
PIK3AP1
|
phosphoinositide-3-kinase adaptor protein 1
|
1.081
|
|
HSP90AB1
|
heat shock protein 90kDa alpha (cytosolic), class B member 1
|
1.08
|
|
HSP90AA1
|
heat shock protein 90kDa alpha (cytosolic), class A member 1
|
1.079
|
|
CSF2
|
colony stimulating factor 2 (granulocyte-macrophage)
|
1.078
|
|
C3
|
complement component 3
|
1.072
|
|
EP300
|
E1A binding protein p300
|
1.071
|
|
IKBKB
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta
|
1.07
|
|
DSP
|
desmoplakin
|
1.066
|
|
XBP1
|
X-box binding protein 1
|
1.064
|
|
SPEN
|
spen family transcriptional repressor
|
1.062
|
|
MNDA
|
myeloid cell nuclear differentiation antigen
|
1.062
|
|
CD2
|
CD2 molecule
|
1.06
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
1.054
|
|
IFNB1
|
interferon, beta 1, fibroblast
|
1.051
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
1.05
|
|
ANPEP
|
alanyl (membrane) aminopeptidase
|
1.05
|
|
CFLAR
|
CASP8 and FADD-like apoptosis regulator
|
1.049
|
|
CYLD
|
cylindromatosis (turban tumor syndrome)
|
1.048
|
|
H1-4
|
H1.4 linker histone, cluster member
|
1.047
|
|
ANXA5
|
annexin A5
|
1.04
|
|
PLEC
|
plectin
|
1.04
|
|
AOPEP
|
aminopeptidase O (putative)
|
1.039
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
1.038
|
|
B3GAT1
|
beta-1,3-glucuronyltransferase 1
|
1.037
|
|
DUSP5
|
dual specificity phosphatase 5
|
1.036
|
|
CHUK
|
conserved helix-loop-helix ubiquitous kinase
|
1.035
|
|
CASP9
|
caspase 9, apoptosis-related cysteine peptidase
|
1.033
|
|
FYN
|
FYN proto-oncogene, Src family tyrosine kinase
|
1.033
|
|
REL
|
v-rel avian reticuloendotheliosis viral oncogene homolog
|
1.031
|
|
FAS
|
Fas cell surface death receptor
|
1.025
|
|
CD81
|
CD81 molecule
|
1.025
|
|
IFNA13
|
interferon, alpha 13
|
1.021
|
|
CYCS
|
cytochrome c, somatic
|
1.017
|
|
RTL10
|
retrotransposon Gag like 10
|
1.016
|
|
LCK
|
LCK proto-oncogene, Src family tyrosine kinase
|
1.016
|
|
TNFSF11
|
tumor necrosis factor (ligand) superfamily, member 11
|
1.013
|
|
NPPB
|
natriuretic peptide B
|
1.011
|
|
TLR4
|
toll-like receptor 4
|
1.01
|
|
MPO
|
myeloperoxidase
|
1.009
|
|
IFNA16
|
interferon, alpha 16
|
1.007
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
1.006
|
|
IFNA14
|
interferon, alpha 14
|
1.006
|
|
IFNA7
|
interferon, alpha 7
|
1.006
|
|
IFNA10
|
interferon, alpha 10
|
1.006
|
|
IFNA21
|
interferon, alpha 21
|
1.006
|
|
IFNA6
|
interferon, alpha 6
|
1.005
|
|
IFNA8
|
interferon, alpha 8
|
1.005
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
1.005
|
|
HP
|
haptoglobin
|
1.005
|
|
IFNA5
|
interferon, alpha 5
|
1.004
|
|
TNFRSF1A
|
tumor necrosis factor receptor superfamily, member 1A
|
1.002
|
|
IFNA4
|
interferon, alpha 4
|
1.0
|
